“China Will Become the Biggest Oncology Market in the World Over the Next 20 Years,” Says Chi-Med CEO Christian Hogg Pharmaceutical Investing
Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones Pharmaceutical Investing
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray Pharmaceutical Investing
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Positive Phase 1/2 Results of AKCEA-APOCIII-LRx Presented at American College of Cardiology Annual Scientific Session & Expo Pharmaceutical Investing
Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis Pharmaceutical Investing
Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
